These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14581091)

  • 1. Stent-based immunosuppressive therapies for the prevention of restenosis.
    Aggarwal M; Tsao PS; Yeung A; Carter AJ
    Cardiovasc Radiat Med; 2003; 4(2):98-107. PubMed ID: 14581091
    [No Abstract]   [Full Text] [Related]  

  • 2. A paclitaxel coated stent used for in-stent restenosis within a sirolimus coated stent fails to protect against recurrent restenosis.
    Bainbridge AD; Muir D; Fath-Ordoubadi F
    Heart; 2005 Jun; 91(6):730. PubMed ID: 15894762
    [No Abstract]   [Full Text] [Related]  

  • 3. [In-stent restenosis: which indications for drug-eluting stent?].
    Eltchaninoff H; Tron C; Cribier A
    Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):198-9. PubMed ID: 12938576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
    Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus eluting stent aborted recurrent distal left main in-stent restenosis involving bifurcation.
    Lee CH; Lemos PA; Serruys PW
    Heart; 2004 May; 90(5):566. PubMed ID: 15084563
    [No Abstract]   [Full Text] [Related]  

  • 6. [From sirolimus to the Cypher stent: stages of the victory against restenosis].
    Fontes I; Barrow D
    Ann Cardiol Angeiol (Paris); 2004 May; 53 Suppl 1():3s-8s. PubMed ID: 15291153
    [No Abstract]   [Full Text] [Related]  

  • 7. ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials.
    Cassese S; De Luca G; Ribichini F; Cernigliaro C; Sansa M; Versaci F; Proietti I; Stankovic G; Stojkovic S; Fernandez-Pereira C; Tomai F; Vassanelli C; Antoniucci D; Serruys PW; Kastrati A; Rodriguez AE
    Atherosclerosis; 2014 Dec; 237(2):410-7. PubMed ID: 25463066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents for secondary prevention of restenosis.
    Kastrati A
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):265-6. PubMed ID: 15505858
    [No Abstract]   [Full Text] [Related]  

  • 10. First drug-eluting coronary stent approved.
    Thompson CA
    Am J Health Syst Pharm; 2003 Jun; 60(12):1210, 1212. PubMed ID: 12845914
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
    Carter AJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-eluting stents: a new treatment in the prevention of restenosis. Part II: Clinical studies.
    Salu KJ; Bosmans JM; Bult H; Vrints CJ
    Acta Cardiol; 2004 Apr; 59(2):165-77 contd. PubMed ID: 15139658
    [No Abstract]   [Full Text] [Related]  

  • 13. Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery.
    Applegate RJ; Draughn T; Yarbrough WD; Little WC
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):391-5. PubMed ID: 16475190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.
    Lowe HC; Schwartz RS; Mac Neill BD; Jang IK; Hayase M; Rogers C; Oesterle SN
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):515-23. PubMed ID: 14624433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 16. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sirolimus-releasing coronary stent: lessons from the Rotterdam experience].
    Lemos PA; Mc Fadden EP; Ong AT; de Feyter PJ; Serruys PW
    Ann Cardiol Angeiol (Paris); 2004 May; 53 Suppl 1():32s-35s. PubMed ID: 15291159
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral sirolimus after bare metal stent implantation.
    Rodriguez A; Fernández-Pereira C; Rodriguez-Alemparte M
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):333-4; author reply 335. PubMed ID: 16821241
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
    Hausleiter J; Kastrati A; Wessely R; Dibra A; Mehilli J; Schratzenstaller T; Graf I; Renke-Gluszko M; Behnisch B; Dirschinger J; Wintermantel E; Schömig A;
    Eur Heart J; 2005 Aug; 26(15):1475-81. PubMed ID: 15975990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.